Fergal Fleming

Dr. Fergal Fleming

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2011 in Anesthesiology
Verified
Journal Article
Open access
PDF file
LGLaurent G. Glance
Laurent G. Glance
ADAndrew W. Dick
Andrew W. Dick
DMDana B. Mukamel
Dana B. Mukamel
FFFergal Fleming
Fergal Fleming
RZRaymond A. Zollo
Raymond A. Zollo
TOTurner M. Osler
Turner M. Osler
Background: The impact of intraoperative erythrocyte transfusion on outcomes of anemic patients undergoing noncardiac surgery has not been well characterized. The objective of this study was to examine the association between blood transfusion and mortality and morbidity in patients with severe anemia (hematocrit less than 30%) who are exposed to one or two units of erythrocytes intraoperatively. Methods: This was a retrospective analysis of the association of blood transfusion and 30-day mortality and 30-day morbidity in 10,100 patients undergoing general, vascular, or orthopedic surgery. We estimated separate multivariate logistic regression models for 30-day mortality and for 30-day complications. Results: Intraoperative blood transfusion was associated with an increased risk of death (odds ratio [OR], 1.29; 95% CI, 1.03-1.62). Patients receiving an intraoperative transfusion were more likely to have pulmonary, septic, wound, or thromboembolic complications, compared with patients not receiving an intraoperative transfusion. Compared with patients who were not transfused, patients receiving one or two units of erythrocytes were more likely to have pulmonary complications (OR, 1.76; 95% CI, 1.48-2.09), sepsis (OR, 1.43; 95% CI, 1.21-1.68), thromboembolic complications (OR, 1.77; 95% CI, 1.32-2.38), and wound complications (OR, 1.87; 95% CI, 1.47-2.37). Conclusions: Intraoperative blood transfusion is associated with a higher risk of mortality and morbidity in surgical patients with severe anemia. It is unknown whether this association is due to the adverse effects of blood transfusion or is, instead, the result of increased blood loss in the patients receiving blood.

1 March 2016 in Surgery
Verified
Journal Article
Closed access
CAChristopher Thomas Aquina
Christopher Thomas Aquina
CPChristian P. Probst
Christian P. Probst
ABAdan Z. Becerra
Adan Z. Becerra
JIJames C. Iannuzzi
James C. Iannuzzi
KKKristin N. Kelly
Kristin N. Kelly
JMJohn R.T. Monson
John R.T. Monson

1 August 2015 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
CPChristian P. Probst
Christian P. Probst
ABAdan Z. Becerra
Adan Z. Becerra
CAChristopher Thomas Aquina
Christopher Thomas Aquina
MTMohamedtaki A. Tejani
Mohamedtaki A. Tejani
SWSteven D. Wexner
Steven D. Wexner
FFFergal Fleming
Fergal Fleming
Many rectal cancer patients experience tumor downstaging and some are found to achieve a pathologic complete response (pCR) after neoadjuvant chemoradiotherapy (nCRT). Previous data suggest that there is an association between the time interval from nCRT completion to surgery and tumor response rates, including pCR. However, these studies have been primarily from single institutions with small sample sizes. The aim of this study was to examine the relationship between a longer interval after nCRT and pCR in a nationally representative cohort of rectal cancer patients. Clinical stage II to III rectal cancer patients undergoing nCRT with a documented surgical resection were selected from the 2006 to 2011 National Cancer Data Base. Multivariable logistic regression analysis was used to assess the association between the nCRT-surgery interval time (8 weeks) and the odds of pCR. The relationship between nCRT-surgery interval, surgical morbidity, and tumor downstaging was also examined. Overall, 17,255 patients met the inclusion criteria. An nCRT-surgery interval time >8 weeks was associated with higher odds of pCR (odds ratio [OR] 1.12, 95% CI 1.01 to 1.25) and tumor downstaging (OR 1.11, 95% CI 1.02 to 1.25). The longer time delay was also associated with lower odds of 30-day readmission (OR 0.82, 95% CI 0.70 to 0.92). An nCRT-surgery interval time >8 weeks results in increased odds of pCR, with no evidence of associated increased surgical complications compared with an interval of 6 to 8 weeks. These data support implementation of a lengthened interval after nCRT to optimize the chances of pCR and perhaps add to the possibility of ultimate organ preservation (nonoperative management).

1 October 2010 in Anesthesiology
Verified
Journal Article
Open access
PDF file
LGLaurent G. Glance
Laurent G. Glance
RWRichard Wissler
Richard Wissler
DMDana B. Mukamel
Dana B. Mukamel
YLYue Li
Yue Li
CDCarol Ann B. Diachun
Carol Ann B. Diachun
ADAndrew W. Dick
Andrew W. Dick
Background: Previous studies have demonstrated that obesity is paradoxically associated with a lower risk of mortality after noncardiac surgery. This study will determine the impact of the modified metabolic syndrome (defined as the presence of obesity, hypertension, and diabetes) on perioperative outcomes. Methods: This study is based on data from 310,208 patients in the American College of Surgeons National Surgical Quality Improvement Program database. We estimated separate multivariate logistic regression models for 30-day mortality and for 30-day complications. Results: Patients with the modified metabolic syndrome who are super obese had a 2-fold increased risk of death (adjusted odds ratio [AOR] 1.99; 95% CI 1.41-2.80). As stratified by body mass index, patients with the modified metabolic syndrome had a 2- to 2.5-fold higher risk of cardiac adverse events (CAE) compared with normal-weight patients: obese (AOR 1.70; 95% CI 1.40-2.07), morbidly obese (AOR 2.01; 95% CI 1.48-2.73), and super obese (AOR 2.66; 95% CI 1.68-4.19). In addition, the risk of acute kidney injury (AKI) was 3- to 7-fold higher in these patients: obese (AOR 3.30; 95% CI 2.75-3.94), morbidly obese (AOR 5.01; 95% CI 3.87-6.49), and super obese (AOR 7.29; 95% CI 5.27-10.1). Conclusion: Patients with the modified metabolic syndrome undergoing noncardiac surgery are at substantially higher risk of complications compared with patients of normal weight.

1 January 2013 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
ARAaron S. Rickles
Aaron S. Rickles
JIJames C. Iannuzzi
James C. Iannuzzi
OMOleg Mironov
Oleg Mironov
ADAndrew-Paul Deeb
Andrew-Paul Deeb
ASAbhiram Sharma
Abhiram Sharma
JMJohn R. T. Monson
John R. T. Monson

1 December 2015 in Annals of Surgery
Verified
Journal Article
Closed access
ARAaron S. Rickles
Aaron S. Rickles
DDDavid W. Dietz
David W. Dietz
GCGeorge J. Chang
George J. Chang
SWSteven D. Wexner
Steven D. Wexner
MBMariana E. Berho
Mariana E. Berho
FFFergal Fleming
Fergal Fleming
Objectives : To identify predictors of positive circumferential resection margin following rectal cancer resection in the United States. Background: Positive circumferential resection margin is associated with a high rate of local recurrence and poor morbidity and mortality for rectal cancer patients. Prior study has shown poor compliance with national rectal cancer guidelines, but whether this finding is reflected in patient outcomes has yet to be shown. Methods: Patients who underwent resection for stage I-III rectal cancer were identified from the 2010–2011 National Cancer Database. The primary outcome was a positive circumferential resection margin. The relationship between patient, hospital, tumor, and treatment-related characteristics was analyzed using bivariate and multivariate analysis. Results: A positive circumferential resection margin was noted in 2859 (17.2%) of the 16,619 patients included. Facility location, clinical T and N stage, histologic type, tumor size, tumor grade, lymphovascular invasion, perineural invasion, type of operation, and operative approach were significant predictors of positive circumferential resection margin on multivariable analysis. Total proctectomy had nearly a 30% increased risk of positive margin compared with partial proctectomy (OR 1.293, 95%CI 1.185–1.411) and a laparoscopic approach had nearly 22% less risk of a positive circumferential resection margin compared with an open approach (OR 0.882, 95%CI 0.790–0.985). Conclusions: Despite advances in surgical technique and multimodality therapy, rates of positive circumferential resection margin remain high in the United States. Several tumor and treatment characteristics were identified as independent risk factors, and advances in rectal cancer care are necessary to approach the outcomes seen in other countries.